Literature DB >> 9553742

BRCA1: a review of structure and putative functions.

J W Paterson1.   

Abstract

BRCA1 is a complex gene implicated in familial breast and ovarian cancer. Although it is almost certainly a tumour suppressor, it is also essential for the normal growth and development of embryonic cells. BRCA1 is probably involved in DNA damage and repair, in cell cycle regulation, and in differentiation of cells. It remains to be established whether all these functions are subserved by single mechanism or pathway. Since the cloning of BRCA1 in 1994, much has been learned about the function of the gene. However, a great deal more still has to be uncovered. The size of the protein coded by the BRCA1 gene and the variety of transcripts argues for a complexity of function and regulation that will provide intellectual and technical challenges for years to come.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9553742     DOI: 10.1155/1998/298530

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  13 in total

1.  BRCA1 partially reverses the transforming activity of the ras oncogene.

Authors:  A Kumar; C Knott; K Kuus-Reichel; M S Saedi
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.

Authors:  Liu Cao; Wenmei Li; Sangsoo Kim; Steven G Brodie; Chu-Xia Deng
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

3.  Application of weighted gene co-expression network analysis to identify the hub genes in H1N1.

Authors:  Bo Sun; Xiang Guo; Xue Wen; Yun-Bo Xie; Wei-Hua Liu; Gui-Fen Pang; Lin-Ying Yang; Qing Zhang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2021-06-15

4.  Prevalence of BRCA1 gene mutation in breast cancer patients in Guangxi, China.

Authors:  Liping Sun; Junjie Liu; Sida Wang; Yuanyuan Chen; Zhixian Li
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

5.  Analysis of BRCA1 Gene Rearrangements in Breast Carcinomas by RT-PCR and ER, PR, HER2NEU Status by IHC and HPE Correlation.

Authors:  Srivatsa Prakhya; Geetha Prakash
Journal:  J Clin Diagn Res       Date:  2012-10-15

6.  PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers?

Authors:  Joseph A De Soto; Chu-Xia Deng
Journal:  Int J Med Sci       Date:  2006-07-15       Impact factor: 3.738

7.  Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features.

Authors:  E M Berns; I L van Staveren; L Verhoog; A M van de Ouweland; M Meijer-van Gelder; H Meijers-Heijboer; H Portengen; J A Foekens; L C Dorssers; J G Klijn
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

8.  The yin-yang of DNA damage response: roles in tumorigenesis and cellular senescence.

Authors:  Xiaoman Li; Hongde Xu; Chongan Xu; Meina Lin; Xiaoyu Song; Fei Yi; Yanling Feng; Kathleen A Coughlan; William Chi-Shing Cho; Sang Soo Kim; Liu Cao
Journal:  Int J Mol Sci       Date:  2013-01-25       Impact factor: 5.923

Review 9.  BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution.

Authors:  Chu-Xia Deng
Journal:  Nucleic Acids Res       Date:  2006-03-06       Impact factor: 16.971

10.  The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids.

Authors:  Qiwei Yang; Sangeeta Nair; Archana Laknaur; Nahed Ismail; Michael P Diamond; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2016-02-17       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.